GlassScriptPhysician profile
Melissa M Yates
NPI 1902952187
$1,264.54
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $915 · 2020: $297 · 2022: $53.04.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $497.88 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $242.96 | 2019-2022 | |
| Hologic Sales and Service, LLC | $125.42 | 2019 | |
| Roche Diagnostics Corporation | $106.82 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $100.00 | 2019 | |
| Smith+Nephew, INC. | $87.58 | 2019 | |
| Becton, Dickinson and Company | $77.65 | 2019 | |
| Merck Sharp & Dohme LLC | $14.63 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.60 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Yates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.